These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3677783)

  • 1. Aporphine derivatives affect ocular function in diverse ways.
    Burke JA; Potter DE
    Curr Eye Res; 1987 Oct; 6(10):1227-36. PubMed ID: 3677783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys.
    Burke JA; Potter DE
    Curr Eye Res; 1986 Sep; 5(9):665-76. PubMed ID: 2876846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ocular effects of xylazine in rabbits, cats, and monkeys.
    Burke JA; Potter DE
    J Ocul Pharmacol; 1986; 2(1):9-21. PubMed ID: 3503099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function.
    Potter DE; Shumate DJ
    J Ocul Pharmacol; 1987; 3(4):309-21. PubMed ID: 3503920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin suppresses sympathetic neuron function and causes ocular hypotension.
    Potter DE; Burke JA; Temple JR
    Curr Eye Res; 1985 Feb; 4(2):87-96. PubMed ID: 4039243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits.
    Potter DE; Burke JA; Ogidigben MJ
    J Auton Pharmacol; 1990 Jun; 10(3):153-61. PubMed ID: 1974256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in ocular function induced by phenylethylamine analogs of dopamine.
    Potter DE; Burke JA; Chang FW
    Curr Eye Res; 1984 Jun; 3(6):851-9. PubMed ID: 6329603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the ocular hypotensive action of ketanserin.
    Chang FW; Burke JA; Potter DE
    J Ocul Pharmacol; 1985; 1(2):137-47. PubMed ID: 3880071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis.
    Potter DE; Ogidigben MJ; Chu TC
    Pharmacology; 1998 Nov; 57(5):249-60. PubMed ID: 9742290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective suppression by bunazosin of alpha-adrenergic agonist evoked elevation of intraocular pressure in sympathectomized rabbit eyes.
    Nishimura K; Kuwayama Y; Matsugi T; Sun N; Shirasawa E
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1761-6. PubMed ID: 8097189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in intraocular pressure, horizontal pupil diameter, and tear production during the use of topical 1% cyclopentolate in cats and rabbits.
    Kovalcuka L; Nikolajenko M
    Open Vet J; 2020 Apr; 10(1):59-67. PubMed ID: 32426258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
    Russell KR; Wang DR; Potter DE
    Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane.
    Potter DE; Ogidigben MJ
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2799-805. PubMed ID: 1680113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics.
    Ogidigben MJ; Potter DE
    Curr Eye Res; 2001 May; 22(5):358-66. PubMed ID: 11600937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action.
    Crosson CE; Burke JA; Chan MF; Potter DE
    Curr Eye Res; 1987 Nov; 6(11):1319-26. PubMed ID: 3427980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits.
    Ogidigben MJ; Potter DE
    J Ocul Pharmacol; 1993; 9(3):187-99. PubMed ID: 7901309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular actions of an octahydrobenzo[f]quinoline: Ha117.
    Potter DE; Ogidigben MJ; Heath AR
    Eur J Pharmacol; 1993 May; 236(1):61-8. PubMed ID: 8100528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central cholinergic stimulation affects ocular functions through sympathetic pathways.
    Liu JH; Dacus AC
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1332-8. PubMed ID: 1973158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.